HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PFAS Remain High Priority For US FDA’s Cosmetics Office – Director Linda Katz

Executive Summary

“We’ve been keeping tabs of the amount of products containing PFAS over the last several years and, unfortunately, we’re not seeing really a lot of it going away,” said Katz, director of the Office of Cosmetics and Colors, at the Independent Beauty Association’s Cosmetics Regulations Workshop.

You may also be interested in...



Cosmetics Industry Still Committed To Reg Modernization, But FDA User-Fee Reauthorization May Not Be Vehicle

A “clean” FDA user-fee reauthorization bill – minus cosmetics modernization provisions – could be the likeliest way forward with user-fee program funding set to elapse at the end of September, a PCPC rep suggested in an email to HBW Insight.

PFAS Testing Standards Under Development As US States Crack Down On Use

ASTM International is developing standards for PFAS in consumer products through a new sub-committee, which will provide guidance on how to prepare and analyze a wide variety of consumer product samples for PFAS.

California’s PFAS Ban In Cosmetics Limited To Intentionally Added Substances, Effective In 2025

Legislation awaiting the governor’s signature in California will ban the “forever chemicals” from cosmetics when intentionally added beginning in 2025, reflecting successful industry advocacy efforts.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel